Who we are

One of Japan’s leading independent strategic communication consultancies providing a full range of services from planning to execution.

An industry pioneer, we have been at the heart of establishing strategic public relations in Japan.
Today we specialize in communication activities for companies and organizations in the healthcare sector.

Our Experience

Our Experience

COSMO has partnered with more than 500 companies, international and domestic, to develop localized communication strategies tailored for the Japanese market.

Our People

Our People

COSMO's staff come from diverse professional backgrounds and are multi-cultural and bilingual. This allows us to assign Japanese and international professionals for the unique requirements of each project.

Our Expertise

Our Expertise

Our seasoned advisors and communication consultants work together with a wide network of key opinion leaders to craft and execute award-winning communication strategies.

News

Health Care and The Environment: The Risks Posed by Climate Change How should the healthcare industry respond?

Health issues caused by the rising temperatures associated with climate change have increased dramatically in recent years. Record heat waves in Europe caused more than 60,000 deaths last year, while a sharp increase in climate disasters such as floods and droughts in Africa have led to worsening food security and the spread of infectious diseases. Japan is no exception, and the number of “Heat Stroke Alerts” issued by the Ministry of the Environment continues to rise each year. This year,

Healthcare and the Environment: Understanding the Movement around PFASHow should the healthcare industry face this issue?

Have you heard of PFAS? Standing for “Per- and Polyfluorinated Substances,” PFAS is the generic name for artificially created organic fluorine compounds. Capable of repelling water and oil, in addition to being highly resistant to heat, chemicals, and ultraviolet rays, they are used in a wide range of applications from water repellents and emulsifiers, to fire extinguishing agents and surface treatments for packaging materials. However, as stable compounds, PFAS have also become known as “forever chemicals” since they can remain

Solving Challenges Around Rare and Intractable Diseases Through Stakeholder Collaboration
Moving toward an era when patients, healthcare professionals, and pharmaceutical companies take action together

The Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (Pharmaceuticals and Medical Devices Act) defines “Rare Disease” as that with fewer than 50,000 patients in Japan. In recent years we have seen a rise in activities being held in Japan and around the world to raise awareness of rare and intractable diseases. These are largely driven by patient groups, but pharmaceutical companies are also starting to more actively provide information and develop new drugs.

Health Care and The Environment: The Risks Posed by Climate Change How should the healthcare industry respond?

Health issues caused by the rising temperatures associated with climate change have increased dramatically in recent years. Record heat waves in Europe caused more than 60,000 deaths last year, while a sharp increase in climate disasters such as floods and droughts in Africa have led to worsening food security and the spread of infectious diseases. Japan is no exception, and the number of “Heat Stroke Alerts” issued by the Ministry of the Environment continues to rise each year. This year,

Healthcare and the Environment: Understanding the Movement around PFASHow should the healthcare industry face this issue?

Have you heard of PFAS? Standing for “Per- and Polyfluorinated Substances,” PFAS is the generic name for artificially created organic fluorine compounds. Capable of repelling water and oil, in addition to being highly resistant to heat, chemicals, and ultraviolet rays, they are used in a wide range of applications from water repellents and emulsifiers, to fire extinguishing agents and surface treatments for packaging materials. However, as stable compounds, PFAS have also become known as “forever chemicals” since they can remain

Solving Challenges Around Rare and Intractable Diseases Through Stakeholder Collaboration
Moving toward an era when patients, healthcare professionals, and pharmaceutical companies take action together

The Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (Pharmaceuticals and Medical Devices Act) defines “Rare Disease” as that with fewer than 50,000 patients in Japan. In recent years we have seen a rise in activities being held in Japan and around the world to raise awareness of rare and intractable diseases. These are largely driven by patient groups, but pharmaceutical companies are also starting to more actively provide information and develop new drugs.

Women’s mental health advice
from a medical practitioner in the field
The importance of creating a supportive atmosphere for
those experiencing mental health issues

It has been claimed in the past that women are twice as likely to suffer from depression as men. Factors may include anxiety caused by naturally-fluctuating female hormones, a work environment in Japan that still makes it difficult for women to work, conflicts arising from relationships within the family, or memories of childhood trauma. Compounding this, recent research suggests that women’s mental health has been further negatively impacted under the COVID-19 pandemic. If we suspect the mental health of someone

COSMO publishes second Patient Insight Report, focusing on women’s cancer

– How patient empowerment affects gynecological and breast cancer patients – The influence media and patient groups have over patients’ attitudes and behaviors toward treatment COSMO’s Patient Insight Report series launched in July 2020. The second volume has now been published, this time focusing on women’s cancer. The report offers quantitative and qualitative insights into how information affects the choices women’s cancer patients make. It first analyzes attitudes and behaviors toward treatment selection, as observed among patients of the three

Medinew and COSMO Joint Webinar: What Patients Expect of Pharmaceutical Companies Today; Insights on Appropriate Information Provision

On October 28, COSMO co-hosted a joint webinar with Medinew, a leading medical marketing magazine with a large readership among the pharmaceutical industry. Highlights from the session have now been made available online as a Medinew seminar report (Japanese language only). Setting out to establish answers to the event’s topic of “What Patients Expect of Pharmaceutical Companies on Appropriate Information Provision Today,” Mr. Yoshiaki Kaneko, CEO of Medinew’s operating company, Pharma Information Network, Inc., opened the webinar with a presentation

Online Survey of 300 Cancer Patients in Japan

Online Survey of 300 Cancer Patients in Japan Real Patient Experiences of Choosing Cancer Treatment Revealed 30% Followed Doctors’ Recommendation Without Sufficient Understanding   TOKYO – July 31, 2020 – In light of the growing number of cancer treatment options now available, COSMO HEALTHCARE has conducted a nationwide online survey of 300 patients across ten major types of cancer in order to gain insight into how informed cancer patients are when deciding on treatment options.

Health Care and The Environment: The Risks Posed by Climate Change How should the healthcare industry respond?

Health issues caused by the rising temperatures associated with climate change have increased dramatically in recent years. Record heat waves in Europe caused more than 60,000 deaths last year, while a sharp increase in climate disasters such as floods and droughts in Africa have led to worsening food security and the spread of infectious diseases. Japan is no exception, and the number of “Heat Stroke Alerts” issued by the Ministry of the Environment continues to rise each year. This year,

Healthcare and the Environment: Understanding the Movement around PFASHow should the healthcare industry face this issue?

Have you heard of PFAS? Standing for “Per- and Polyfluorinated Substances,” PFAS is the generic name for artificially created organic fluorine compounds. Capable of repelling water and oil, in addition to being highly resistant to heat, chemicals, and ultraviolet rays, they are used in a wide range of applications from water repellents and emulsifiers, to fire extinguishing agents and surface treatments for packaging materials. However, as stable compounds, PFAS have also become known as “forever chemicals” since they can remain

HIV Prevention Focusing on Communities

– Interview with Kota Iwahashi, President of akta – Understanding how akta became a NPO success story Patient empowerment and greater patient participation in managing one’s own health care have gained attention in recent years. One area where this trend has made particular progress is that of HIV and AIDS. As president of akta, Kota Iwahashi has been at the forefront of anti-HIV efforts in Japan. In a sequel to our last newsletter issue, COSMO wanted to learn more about

<HIV today> Latest Information and Changing Mindsets: Shifting to a community-based approach that puts people and the community at the center – Interview with Kota Iwahashi, President of akta –

More than a year has passed since the COVID-19 pandemic began. Among the many consequences being felt by us all, one issue that stands out is the impact on operations at public health centers, a body that tended to garner little attention in the past. The past year has underscored the important role public health centers play, but has also shone a light on the difficulties created when such centers are forced to focus exclusively on one disease, in this

COSMO Healthcare Interview: “Japan in 10 Minutes”

No. 2: Dr. Masaharu Tsubokura, MD, of Hirata Central Hospital in Fukushima As the second segment of COSMO’s “Japan in 10 Minutes” interview series, our CEO Kumi Sato interviews with Dr. Tsubokura, of Hirata Central Hospital in Japan. In the interview, Dr. Tsubokura discussed the situation about PCR testing and Antibody testing in Japan.

COSMO Healthcare YouTube Channel Opened

~ 1st Video “COSMO Healthcare Special Interview –Japan in 10 Minutes” COSMO Healthcare has now opened a YouTube channel to disseminate medical information and news of industry trends.

Careers

Interested in working with us?

Since its founding in 1960, COSMO has been a pioneering force behind countless transformations in Japan’s public relations industry. To this day, each of us carry this trailblazer spirit as a company of leaders, and never followers.

More

Contact & Access

7F Azabu Kaisei Building,
1-8-10 Azabudai
Minato-ku, Tokyo,
Japan 〒106-0041
TEL +81(0)3-5561-2911
FAX +81(0)3-5561-2912

Contact us
岩下裕司Home